For Consumers
Final Rule Promotes Safe Use of Dietary Supplements
|
|
Some dietary supplements are beneficial when taken appropriately. Calcium supplements may strengthen bones and folic acid lowers the risk of certain birth defects. But some supplements pose health risks. They may contain harmful ingredients or be improperly manufactured or handled.
On June 22, 2007, FDA announced a final rule establishing current good manufacturing practice requirements (CGMPs) for dietary supplements. In addition, by the end of the year, industry will be required to report all serious dietary supplement adverse events to FDA.
Ensuring Quality
Under the final rule, manufacturers are required to evaluate the identity, purity, quality, strength, and composition of dietary supplements.
"The dietary supplement CGMPs should increase consumers' confidence in the quality of the dietary supplement products that they purchase," says Robert E. Brackett, PhD, Director of FDA's Center for Food Safety and Applied Nutrition. "These regulations provide more accountability in the manufacturing process so that consumers can be confident that the products they purchase contain what is on the label."
The final rule aims to ensure that dietary supplements do NOT have:
- wrong ingredients
- too much or too little of a dietary ingredient
- improper packaging
- improper labeling
- contamination problems due to natural toxins, bacteria, pesticides, glass, lead, or other substances
How FDA Regulates Supplements
The final rule on CGMPs is a critical component of the Dietary Supplement Health and Education Act of 1994 (DSHEA).
Under DSHEA, dietary supplements are regulated like foods. Unlike new drugs, dietary supplements don't have to go through review by FDA for safety and effectiveness or be "approved" before they can be marketed. But manufacturers must provide premarket notice and evidence of safety for any supplements they plan to sell that contain dietary ingredients that were not marketed as dietary supplements before DSHEA was passed—except that the premarket notice is not needed if the new dietary ingredient had previously been used as in ingredient in food.
Manufacturers are responsible for substantiating the safety of dietary ingredients and also for determining that certain structure/function and other claims they make about their products are substantiated by adequate evidence to show that the claims are truthful and not misleading.
FDA evaluates the safety of dietary supplements after they are on the market through research and adverse event monitoring. The agency is responsible for taking action against any unsafe dietary supplement product after it reaches the market.
The final rule on CGMPs gives industry clear expectations for manufacturing, packaging, labeling, and holding dietary supplements. If dietary supplements are found to be contaminated or lacking the appropriate ingredients, FDA will consider those products in violation of the law and will evaluate its enforcement options.
Advice for Consumers
- Talk with a health care provider before using a dietary supplement. This is a good idea, especially for certain population groups. If you are pregnant, nursing a baby, or have a chronic medical condition such as diabetes or heart disease, be sure to consult your doctor or pharmacist before purchasing or taking any supplement.
- Know that some supplements may interact with prescription and over-the-counter medicines. Taking a combination of supplements or using these products together with medications (whether prescription or OTC drugs) could produce adverse effects, some of which could be life-threatening. For example, Coumadin (a prescription medicine), ginkgo biloba (an herbal supplement), aspirin (an OTC drug), and vitamin E (a vitamin supplement) can each thin the blood, and taking any of these products together can increase the potential for internal bleeding.
- Inform your doctor about all the supplements you use, especially before surgery. Some supplements can have unwanted effects during surgery. You may be asked to stop taking these products at least 2-3 weeks ahead of the procedure to avoid potentially dangerous interactions. These interactions could cause changes in heart rate or blood pressure, increased bleeding, or other problems that could adversely affect the outcome of your surgery.
- Report adverse effects from the use of dietary supplements to MedWatch. If you think you have been harmed by a dietary supplement, contact your health provider and report it to FDA's MedWatch program.
This article appears on FDA's Consumer Updates page, which features the latest on all FDA-regulated products.
Date Posted: June 22, 2007
Recent Consumer Updates
- FDA Unveils Safe Use Initiative to Reduce Harm From Medication Use
- FDA's MedWatch Safety Alerts: October 2009
- FDA, WebMD Expand Health Information Partnership
- Improper Use of Decorative Contact Lenses May Haunt You
- The Word is Out on Unapproved H1N1 Products
- Improper Use of Decorative Contact Lenses May Haunt You (video)
- LASIK: Quality of Life Project, Warning Letters to Facilities
- A New Online Guide to Hearing Aids
- Reducing Radiation from Medical X-rays (video)
- FDA's International Posts: Improving the Safety of Imported Food and Medical Products
- Hearing Aids and Personal Sound Amplifiers: Know the Difference
- Cooperative Program Ensures Safe Shellfish (slideshow)
- Cooperative Programs Help Keep Food Safe
- Cooperative Program Ensures Safe Shellfish
- FDA's MedWatch Safety Alerts: September 2009
- Avoiding Medication Mistakes (video)
- Fortify Your Knowledge About Vitamins (video)
- FDA 101: Product Recalls (video)
- Avoiding Drug Interactions (video)
- Food Allergies: Reducing the Risks (video)
- Regulating Tobacco: Q&A with Lawrence Deyton, M.S.P.H., M.D.
- Warning on Stolen Albuterol Sulfate Inhalation Solution and Ipratropium Bromide Inhalation Solution
- Generic Drug Roundup: September 2009
- Vaccines Approved for H1N1 Influenza Virus
- Lowering Salt in Your Diet
- 2009-2010 Seasonal Influenza Vaccines
- A Close Look at Ultrasound
- A Parent's Guide to Kids' Vaccines
- Update to FDA Alert About Stolen Insulin
- Facing Facts About Acne
- FDA Expands Access to Investigational Drugs
- FDA's MedWatch Safety Alerts: August 2009
- Warning on Body Building Products Marketed as Containing Steroids or Steroid-Like Substances
- Treating Head Lice
- FDA Warns of Health Risks Posed by E-Cigarettes
- Reporting Drug Quality Problems
- Tablet Splitting: A Risky Practice
- Safe Use of Flea and Tick Products in Pets
- Update on Recalled Nestlé Toll House Cookie Dough
- FDA Takes Action on Darvon and Other Pain Medications
- FDA Improves Egg Safety
- FDA Warns Not to Consume Two Liquid “Energy” Products
- Chantix and Zyban to Get Boxed Warning on Serious Mental Health Events
- Advertencia sobre productos para fisicoculturismo comercializados como productos que contienen esteroides o sustancias similares a los esteroides
- Acetaminophen and Liver Injury: Q & A for Consumers
- Illuminating the Hazards of Powerful Laser Products
- El acetaminofeno y las lesiones hepáticas: Preguntas y respuestas para los consumidores
- FDA Warns Not to Eat Two Brands of Pistachios
- FDA Advisory About Levemir Insulin
- Ensuring Safe Use of Contact Lens Solution
- Warnings on Three Zicam Intranasal Zinc Products
- Patients Alerted to Pacemaker Recall
- FDA 101: Animal Feed
- Are You Taking Medication as Prescribed?
- Practice Hospital Bed Safety
- Giving Medication to Children
- Consumers Warned Not to Use Clarcon Skin Products
- FDA's MedWatch Safety Alerts: June 2009
- Advertencias sobre tres productos intranasales Zicam que contienen cinc
- La FDA promueve la apertura y la transparencia hacia el público
- FDA Promotes Openness and Transparency to Public
- New Labeling Required for OTC Pain and Fever Medicines
- H1N1 Flu: FDA Responds Quickly to Protect the Public's Health
- Treating Cushing's Disease in Dogs
- Safety Concerns About Testosterone Gel
- The Scoop on Whole Grains
- Warning on Hydroxycut Products
- FDA's MedWatch Safety Alerts: April 2009
- Itching for Allergy Relief?
- FDA Warns About Raw Alfalfa Sprouts
- FDA 101: Clinical Trials and Institutional Review Boards
- Sprout Recall Due to Potential Contamination with Listeria
- Safety Concerns and Labeling Changes for Psoriasis Drug Raptiva
- Pistachio Recall Expanded
- On the Road Again: FDA's Mobile Laboratories
- More Weight Loss Products Added to Consumer Alert
- Some "Vanilla Extract" Produced in Mexico is No Bargain
- Algunos "extractos de vainilla" producidos en México no son una buena oferta
- Insulin Pens are Not for Sharing
- FDA's MedWatch Safety Alerts: March 2009
- Warning on Potentially Contaminated Cheese
- Problems Digesting Dairy Products?
- Your Guide to Reporting Problems to FDA
- The Possible Dangers of Buying Medicines Over the Internet
- Developing Orphan Products: FDA and Rare Disease Day
- Should Your Child Be in a Clinical Trial?
- FDA 101: How to Use the Consumer Complaint System and MedWatch
- Medications for High Blood Pressure
- A Guide to Safe Use of Pain Medicine
- Fortify Your Knowledge About Vitamins
- Safe Handling Tips for Pet Foods and Treats
- Coping with Memory Loss
- Pet Turtles: Cute But Contaminated with Salmonella
- Reducing Radiation from Medical X-rays
- Find the Latest Drug Product and Safety Information
- Improper Use of Skin Numbing Products Can Be Deadly
- Food Allergies: Reducing the Risks
- FDA Web Page on Salmonella and Peanut Products
- FDA publica la orientación final sobre la regulación de animales genéticamente modificados
- Genetically Engineered Animals Diagram
- FDA Releases Final Guidance on Genetically Engineered Animals
- Understanding Antidepressant Medications
- Caution in Feeding Chicken Jerky to Dogs
- Caution to Dog Owners About Chicken Jerky Products
- Prescription Drug Leaflets Need Improvement
- Mejoras necesarias en los prospectos de los medicamentos de venta con receta
- Kidney Risk Spurs Warning on Bowel Cleansers
- Some Medications and Driving Don't Mix
- Get Set for Winter Illness Season
- FDA Beyond Our Borders
- FDA and WebMD Form Partnership
- La FDA advierte a Bayer acerca de dos productos de Aspirina no aprobados
- Avoiding Drug Interactions
- FDA Acts to Reduce Risk of Salmonella Infections
- Consejos de seguridad de los alimentos para unas fiestas saludables
- Focusing on Contact Lens Safety
- FDA Safety Update: Asthma Medications
- Think Before You Ink: Are Tattoos Safe?
- Use Your Microwave Safely
- FDA 101: Product Recalls - From First Alert to Effectiveness Checks
- Use Eye Cosmetics Safely
- 6 Tips to Avoid Medication Mistakes
- Food Safety Tips for Healthy Holidays
- FDA Warns Bayer About Two Unapproved Aspirin Products Questions and Answers for Consumers
- Using Over-the-Counter Cough and Cold Products in Children
- Recalls and Melamine Contamination
- New Initiative to Improve Availability of Generics
- New Generic Drug Program: Q & A with Gary J. Buehler
- Health Information Advisory on Infant Formula
- Is It Really FDA Approved?
- Keeping Watch Over Direct-to-Consumer Ads
- "In-Body" Pediatric Devices Pose Unique Challenges
- FDA Requires Stronger Fungal Infection Warning for TNF Blockers
- Sun Safety: Save Your Skin!
- Outsmarting Poison Ivy and Other Poisonous Plants
- Irradiation: A Safe Measure for Safer Iceberg Lettuce and Spinach
- Warning on Certain Mussel Products from Bantry Bay Seafoods
- New Steps to Improve Advisory Committee Processes
- Strengthening the Advisory Committee Process
- Are You Storing Food Safely?
- Está almacenando los alimentos en forma segura?
- Living with Fibromyalgia, Drugs Approved to Manage Pain
- Stronger Warnings Requested for Fluoroquinolones
- FDA 101: Advisory Committees
- Wrinkle Relief: Injectable Cosmetic Fillers
- FDA 101: Regulating Biological Products
- Regulation of Genetically Engineered Animals
- Stay Healthy While Traveling Abroad
- Cómo desechar los medicamentos sin usar
- Pet Food Products Seized at PETCO Distribution Center
- Radiology and Children: Extra Care Required
- Beware of Bug Bites and Stings
- Heartworm Prevention in Your Pet
- Sea cuidadoso de fraude del cáncer en línea
- Warning for Regranex—Cream for Leg and Foot Ulcers
- Albuterol Inhalers: Time to Transition
- Inhaladores de albuterol: El momento de la transición
- Pregnant Women to Benefit from Better Information
- Sentinel System to Monitor Medical Product Safety
- Start at the Store:
7 Ways to Prevent Foodborne Illness - An FDA Guide to Drug Safety Terms
- Facts About Crohn's Disease
- Combating Antibiotic Resistance
- Strengthening Beef Safety
- New Type of Latex Glove Cleared
- Salmonella Illnesses May be Linked to Recalled Cereal
- Bio-Identicals: Sorting Myths from Facts
- Sea cuidadoso con las cremas y los ungüentos de venta sin receta médica
- Use Caution with Over-the-Counter Creams, Ointments
- Food Label Helps Consumers Make Healthier Choices
- Las etiquetas de los alimentos ayudan a los consumidores a tomar decisiones más saludables
- Avoid Fetal "Keepsake" Images, Heartbeat Monitors
- Getting Up to Date on Glucose Meters
- Artículos en Español (Consumer Updates in Spanish)
- FDA 101: Medication Errors
- Denture Cleansers: Allergic Reactions and Misuse
- Generic Drug Roundup: March 2008
- Nexium Approved for Children 1 to 11 Years Old
- FDA's Strategic Plan: Charting Our Course for the Future
- Icy Hot Heat Therapy Products Recalled
- Charges Filed in Contaminated Pet Food Scheme
- "My Medicines" … This Brochure Can be a Lifesaver
- New Safety Warnings for Chantix
- Serious Health Risks with Antiepileptic Drugs
- Thyroid Medications: Q & A with Mary Parks, M.D.
- Ongoing Review of Cholesterol Drug Vytorin
- Vital Facts About HIV Home Test Kits
- Una guía para los padres sobre las vacunas de los hijos
- Update to Label on Birth Control Patch
- OTC Cough and Cold Products: Not For Infants and Children Under 2 Years of Age
- Animal Cloning and Food Safety
- Second Safety Warning on Fentanyl Skin Patch
- Warning Required for Nonoxynol 9 Over-the-Counter Contraceptives
- How Safe are Color Additives?
- FDA 101: Infant Formula
- Workshop on Over-the-Counter Drug Use in Adolescents
- Potentially Harmful "Cosmetic" Eye Product Seized
- Labeling Revised for Diabetes Drug Avandia
- Modificación de rotulación del medicamento contra la diabetes Avandia
- Nonprescription Zyrtec-D for Allergies
- Medtronic Recalls Sprint Fidelis Cardiac Leads: Questions and Answers for Consumers
- Human Gene Therapies: Novel Product Development Q&A with Celia M. Witten, Ph.D, M.D.
- Recognizing Potentially Unsafe Imported Toothpastes
- Ensuring the Safety of Imported Products: Q & A with Deborah Ralston
- Lamisil Approved to Treat Scalp Ringworm in Children
- Renovada legislación mejora la seguridad de los productos regulados por la FDA: Preguntas frecuentes
- Have You Given Blood Lately?
- Renewed Legislation Improves Safety of FDA-Regulated Products
- Serious Side Effects with Cancer Pain Drug
- Nuevo Programa de Medicamentos Genéricos de la FDA Preguntas y respuestas con Gary J. Buehler, RPh.
- Nasal Influenza Vaccine Approved for Younger Children
- FDA Launches Drug Safety Newsletter
- Improving Medical Products for Children: Q & A with Dianne Murphy, M.D.
- Evista Approved for Reducing Breast Cancer Risk
- Promoción de la seguridad alimentaria en Puerto Rico
- Promoting Food Safety in Puerto Rico
- Abbott Issues Correction for Certain Blood Glucose Meters
- The Critical Path: Making Medical Products Better, Faster, and Cheaper
- Building a Stronger Defense Against Bioterrorism
- FDA Aims to Upgrade Sunscreen Labeling
- Drug Approved to Treat Two Psychiatric Conditions in Children and Adolescents
- The Skinny on Liposuction
- Warning for Nursing Mothers Taking Codeine
- Use Caution with Cough and Cold Medicines for Children
- Stronger Heart Warning on Diabetes Drugs
- Improving Access to HIV/AIDS Drugs Abroad
- New HIV Drug for Adults
- Side Effects of Sleep Drugs
- FDA Releases Statement on Gene Therapy Trial
- First Artificial Neck Disc Approved
- Ad Spotlights Teen Abuse of Medicinal Drugs
- Test Detects the Spread of Breast Cancer
- Spot the Block: Get Your Food Facts First
- How FDA Regulates Seafood: FDA Detains Imports of Farm-Raised Chinese Seafood
- First Quick Test for Malaria
- Removing Hair Safely
- Beware of Ticks … & Lyme Disease
- New Option for Rare Form of Hypertension
- Nueva información de seguridad con respecto a la droga Rosiglitazone tratamiento de la diabetes
- FDA's Standards for High Quality Foods
- CARVER + Shock: Enhancing Food Defense
- Recognizing Recalled Foods
- FDA Launches Tomato Safety Initiative
- Respirators for Public Health Emergencies
- Medication Guides for Certain Prescription Products
- Continuous 7-Day Glucose Monitoring System
- Strengthening Drug Safety
- The Special Risks of Pharmacy Compounding
- Managing Drug Safety Issues Q and A with Paul Seligman, M.D., M.P.H.
- Recall: Complete MoisturePlus Contact Lens Solution
- New Safety Information on Diabetes Drug Rosiglitazone
- Risks for ADHD Drugs Outlined in Patient Guides
- Barbecue Basics: Tips to Prevent Foodborne Illness
- New Ointment to Treat Impetigo
- Rapid Response Helps Save Limbs
- Low Risk of Illness From Food Containing Melamine
- Test Determines Risk of Breast Cancer Returning
- Rapid Test Detects Viral Meningitis
- New Warnings Proposed for Antidepressants
- FDA Seizes Implantable Devices
- Pet Turtles Pose Salmonella Risk
- Contaminant Found in Second Pet Food Ingredient
- Withdrawal of Parkinson's Treatment - Pergolide
- Stronger Warning Proposed for Xolair
- Stronger Warning Proposed for Xolair
- Dog Treats May Present Health Hazard
- Pet Food Recall: FDA's Ongoing Investigation
- Nueva iniciativa para mejorar la disponibilidad de medicamentos genéricos
- The Benefits and Risks of Pain Relievers Q & A on NSAIDs with Sharon Hertz, M.D.
- How FDA Works to Keep Produce Safe


